FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213324688> ?p ?o ?g. }

• W4213324688 endingPage "1414" @default.
• W4213324688 startingPage "1403" @default.
• W4213324688 abstract "Randomized controlled trials have demonstrated the benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2is) in people with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). However, real-world data on CKD progression and the development of end-stage kidney disease (ESKD) remains scarce. Our aim was to study renal outcomes of people with diabetic kidney disease (DKD) using SGLT2is in a highly prevalent DKD population.Between 2016 and 2019 we recruited T2DM patients in the renal and diabetic clinics in a regional hospital in Singapore. Patients prescribed SGLT2is were compared with those on standard anti-diabetic and renoprotective treatment. The outcome measures were CKD progression [a ≥25% decrease from baseline and worsening of estimated glomerular filtration rate (eGFR) categories according to the Kidney Disease: Improving Global Outcomes guidelines] and ESKD (eGFR <15 mL/min/1.73 m2).We analysed a total of 4446 subjects; 1598 were on SGLT2is. There was a significant reduction in CKD progression {hazard ratio [HR] 0.60 [95% confidence interval (CI) 0.49-0.74]} with SGLT2is. The HR for eGFR ≥45 mL/min/1.73 m2 and 15-44 mL/min/1.73 m2 was 0.60 (95% CI 0.47-0.76) and 0.43 (95% CI 0.23-0.66), respectively. There was also a reduction in risk for developing ESKD for the entire cohort [HR 0.33 (95% CI 0.17-0.65)] and eGFR 15-44 mL/min/1.73 m2 [HR 0.24 (95% CI 0.09-0.66)]. Compared with canagliflozin and dapagliflozin, empagliflozin showed a sustained risk reduction of renal outcomes across CKD stages 1-4.This real-world study demonstrates the benefits of SGLT2is on CKD progression and ESKD. The effect is more pronounced in moderate to advanced CKD patients." @default.
• W4213324688 created "2022-02-24" @default.
• W4213324688 creator A5011330789 @default.
• W4213324688 creator A5013554156 @default.
• W4213324688 creator A5014804058 @default.
• W4213324688 creator A5018013040 @default.
• W4213324688 creator A5024131767 @default.
• W4213324688 creator A5028724325 @default.
• W4213324688 creator A5049030871 @default.
• W4213324688 creator A5054600137 @default.
• W4213324688 creator A5066365214 @default.
• W4213324688 creator A5090814792 @default.
• W4213324688 creator A5090815103 @default.
• W4213324688 creator A5090990214 @default.
• W4213324688 date "2022-02-16" @default.
• W4213324688 modified "2023-10-10" @default.
• W4213324688 title "A real-world study on SGLT2 inhibitors and diabetic kidney disease progression" @default.
• W4213324688 cites W2030192134 @default.
• W4213324688 cites W2077038286 @default.
• W4213324688 cites W2113760558 @default.
• W4213324688 cites W2146264128 @default.
• W4213324688 cites W2155965977 @default.
• W4213324688 cites W2338198328 @default.
• W4213324688 cites W2424539745 @default.
• W4213324688 cites W2492672367 @default.
• W4213324688 cites W2551250462 @default.
• W4213324688 cites W2583476095 @default.
• W4213324688 cites W2607031541 @default.
• W4213324688 cites W2626446274 @default.
• W4213324688 cites W2768151124 @default.
• W4213324688 cites W2780645176 @default.
• W4213324688 cites W2886679183 @default.
• W4213324688 cites W2888859009 @default.
• W4213324688 cites W2890959675 @default.
• W4213324688 cites W2898388822 @default.
• W4213324688 cites W2900413769 @default.
• W4213324688 cites W2900442056 @default.
• W4213324688 cites W2939222610 @default.
• W4213324688 cites W2949665037 @default.
• W4213324688 cites W2971414122 @default.
• W4213324688 cites W2996130540 @default.
• W4213324688 cites W2998437623 @default.
• W4213324688 cites W3005957464 @default.
• W4213324688 cites W3021208389 @default.
• W4213324688 cites W3022616650 @default.
• W4213324688 cites W3033155538 @default.
• W4213324688 cites W3042268527 @default.
• W4213324688 cites W3082389140 @default.
• W4213324688 cites W3088173406 @default.
• W4213324688 cites W3089283105 @default.
• W4213324688 cites W3095570107 @default.
• W4213324688 cites W3109512796 @default.
• W4213324688 cites W3120821309 @default.
• W4213324688 cites W3135503392 @default.
• W4213324688 cites W3152913209 @default.
• W4213324688 cites W3163210575 @default.
• W4213324688 cites W3176213715 @default.
• W4213324688 cites W3196144564 @default.
• W4213324688 cites W4206532513 @default.
• W4213324688 cites W4235787011 @default.
• W4213324688 cites W4285719527 @default.
• W4213324688 doi "https://doi.org/10.1093/ckj/sfac044" @default.
• W4213324688 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35756732" @default.
• W4213324688 hasPublicationYear "2022" @default.
• W4213324688 type Work @default.
• W4213324688 citedByCount "4" @default.
• W4213324688 countsByYear W42133246882022 @default.
• W4213324688 countsByYear W42133246882023 @default.
• W4213324688 crossrefType "journal-article" @default.
• W4213324688 hasAuthorship W4213324688A5011330789 @default.
• W4213324688 hasAuthorship W4213324688A5013554156 @default.
• W4213324688 hasAuthorship W4213324688A5014804058 @default.
• W4213324688 hasAuthorship W4213324688A5018013040 @default.
• W4213324688 hasAuthorship W4213324688A5024131767 @default.
• W4213324688 hasAuthorship W4213324688A5028724325 @default.
• W4213324688 hasAuthorship W4213324688A5049030871 @default.
• W4213324688 hasAuthorship W4213324688A5054600137 @default.
• W4213324688 hasAuthorship W4213324688A5066365214 @default.
• W4213324688 hasAuthorship W4213324688A5090814792 @default.
• W4213324688 hasAuthorship W4213324688A5090815103 @default.
• W4213324688 hasAuthorship W4213324688A5090990214 @default.
• W4213324688 hasBestOaLocation W42133246882 @default.
• W4213324688 hasConcept C126322002 @default.
• W4213324688 hasConcept C126894567 @default.
• W4213324688 hasConcept C134018914 @default.
• W4213324688 hasConcept C159641895 @default.
• W4213324688 hasConcept C207103383 @default.
• W4213324688 hasConcept C2776174234 @default.
• W4213324688 hasConcept C2777180221 @default.
• W4213324688 hasConcept C2777422806 @default.
• W4213324688 hasConcept C2778653478 @default.
• W4213324688 hasConcept C2908647359 @default.
• W4213324688 hasConcept C44249647 @default.
• W4213324688 hasConcept C555293320 @default.
• W4213324688 hasConcept C71924100 @default.
• W4213324688 hasConcept C99454951 @default.
• W4213324688 hasConceptScore W4213324688C126322002 @default.
• W4213324688 hasConceptScore W4213324688C126894567 @default.

• next